Orbus

Orbus Software Accelerates with 56% SaaS Platform Growth in 2023

Retrieved on: 
목요일, 2월 1, 2024
Professional Services, Data Management, Business, Technology, Software, Networks, Growth, Architect, ARR, Mizuho Bank, ASICS, Web, Alaska Airlines, Gartner, Name, UPS, United Parcel Service, Risk, Golub Capital, Orbus, Software as a service, AutoZone, Video game

Enterprise transformation platform provider Orbus Software , today announced it has met its forecasted annual recurring revenue (ARR) target for 2023, achieving 30% year-on-year growth.

Key Points: 
  • Enterprise transformation platform provider Orbus Software , today announced it has met its forecasted annual recurring revenue (ARR) target for 2023, achieving 30% year-on-year growth.
  • The ARR of the company’s flagship product and software-as-a-service (SaaS) platform OrbusInfinity grew by 56% in 2023, which is 26 times greater than its value in December 2020.
  • This key milestone enabled Orbus to hit profitability in Q3 2023, a quarter earlier than planned.
  • Throughout 2023, Orbus maintained its net revenue retention rate of 112% from 2022 and increased cloud customer retention from 96% in 2022 to 97% in 2023.

BoostUp.ai Introduces In-Depth Revenue Operations MasterClass Featuring Expert Instructors

Retrieved on: 
목요일, 11월 16, 2023
MasterClass, Organization, Orbus, Marketing, Olumo Rock, Data management, Systems Tool Kit, Knowledge, System

SANTA CLARA, Calif., Nov. 16, 2023 /PRNewswire/ -- BoostUp.ai announced the launch of its RevOps MasterClass, a comprehensive set of courses designed for sales, marketing, and customer success operations professionals to master the art of revenue operations.

Key Points: 
  • SANTA CLARA, Calif., Nov. 16, 2023 /PRNewswire/ -- BoostUp.ai announced the launch of its RevOps MasterClass, a comprehensive set of courses designed for sales, marketing, and customer success operations professionals to master the art of revenue operations.
  • The program's initial lineup of contributors includes some of the most experienced operations leaders, and will continue to grow with new course materials in 2024.
  • The course covers six critical areas of operations: Revenue Operations, Sales Operations, Marketing Operations, Customer Success Operations, Data Management & Analytics, and Systems & Tools.
  • Instructors like Matt Durazzani, Chief Revenue Officer at Olumo and former global ops leader at DOMO, MX and Orbus, bring a wealth of real-world knowledge to the program.

Orbus Software Cloud Annual Recurring Revenue Grows 77%

Retrieved on: 
목요일, 8월 3, 2023
Software, Technology, Networks, Data Management, Customer success, Washington State Department of Information Services, Software as a service, Partnership, IRAP, Mattamy National Cycling Centre, Microsoft, Customer engagement, Government, Human voice, Emerging technologies, Organization, Medtronic, Data analysis, Health care, Customer, ARR, Mining, Engineering, Alaska Airlines, Magic, Orbus, CFO, Growth, Social, Forrester, Irving Oil, Washington State Department of Social and Health Services, Food delivery, Management, Mobile phone

Enterprise architecture solutions provider, Orbus Software , has achieved strong revenue growth in the last year.

Key Points: 
  • Enterprise architecture solutions provider, Orbus Software , has achieved strong revenue growth in the last year.
  • During this period, the SaaS business grew by 77%, with a net revenue retention of 112% and a customer retention rate of more than 97%.
  • Over 50% of the company’s growth came from EMEA, with government and finance industries accounting for more than half of this.
  • Gareth Burton, CEO of Orbus Software, noted, “Orbus's continued strong growth is fundamentally driven by the value our solutions provide and the commitment of our global team.

Orbus Therapeutics Enters Exclusive License Agreement for Intellectual Property Related to Treatment of Rare Pediatric Syndrome with Eflornithine

Retrieved on: 
화요일, 1월 10, 2023
MSU, PALO, Therapy, Glioma, Michigan State University, BABS, Spectrum Health, Patient, Radiation, Cancer, Eflornithine, Pharmaceutical industry, Orbus

"We are delighted to enter into this agreement with Orbus Therapeutics,” said Anupam Jhingran, Technology Manager with MSU Technologies, the technology transfer office of MSU.

Key Points: 
  • "We are delighted to enter into this agreement with Orbus Therapeutics,” said Anupam Jhingran, Technology Manager with MSU Technologies, the technology transfer office of MSU.
  • “We believe that Orbus Therapeutics' unique strength in developing new treatment options in the rare disease space and their current clinical development of eflornithine makes them the ideal partner to move this effort forward."
  • The company plans to expand its activities to include development and future commercialization of its eflornithine oral solution in BABS in parallel with its ongoing efforts in malignant glioma.
  • “These children face significant neurological and development hurdles as a result of this gain-of-function mutation,” said Bob Myers, Chief Executive Officer of Orbus.